XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tharos who wrote (7256)	9/19/1998 10:23:00 AM
From: Robert K.	Read Replies (2) of 17367

Let us not forget that meningococcemia is a sepsis condition. Neuprex has gotten remarkably little press so far IMO considering late stage status.. Not even listed in "facts and comparisions" or in the USPDI. If it does deserve recognition, it could come suddenly. I am very surprised it is in 50 or so hospitials and still is a virtual unknown. All IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next